Resistance training activates distinct biological pathways in aging muscle, but their translation from laboratory to clinical practice varies dramatically. Mitochondrial adaptations demonstrate consistent benefits across both preclinical and human studies, while protein metabolism regulation and inflammation responses show poor translation between research models and real-world outcomes. The Hippo pathway's YAP/TAZ proteins emerge as promising mechanistic links between mechanical loading and satellite cell activation. This translational disconnect represents a critical gap in sarcopenia research. While animal studies clearly demonstrate how resistance training triggers muscle protein synthesis and reduces inflammatory markers, these mechanisms don't reliably predict clinical outcomes in older adults. The finding suggests that mitochondrial health may be the most reliable target for resistance training interventions, offering a more predictable path to preserving muscle mass and function with aging. This analysis challenges the assumption that understanding biological mechanisms automatically translates to effective treatments. For practitioners, it emphasizes focusing on mitochondrial-supporting protocols while remaining cautious about overpromising benefits based solely on molecular evidence. The research underscores the complexity of aging biology and the need for more sophisticated translational approaches.